Viral Load Monitoring | Aptima HCV Quant ...
Demand More from Your HCV NAAT
The Aptima HCV Quant Dx assay detects and quantitates HCV RNA and is intended for use as an aid in:
The Aptima HCV Quant Dx Assay intended use is to:
Confirm HCV Infection
Monitor Viral Load
HCV Treatment Is Evolving. Now HCV Testing Is Too.
The Aptima HCV Quant Dx assay meets the 2021 American Association for the Study of Liver Diseases (AASLD) recommendations for an FDA-approved quantitative or qualitative nucleic acid test (LoD ≤25 IU/mL) to determine sustained virological response (SVR). It employs real-time transcription-mediated amplification (RT-TMA) technology on Hologic’s Panther® system—and gives you unparalleled performance across several essential parameters.
Performance by design
The robust design of the Aptima HCV Quant Dx assay incorporates multiple primers and probes within a highly conserved region of HCV RNA (5’ UTR) to detect and quantitate across genotypes 1 – 6:
Redefining sensitivity: Detect even the lowest-level concentrations of HCV across all major genotypes and quantify HCV for optimal treatment monitoring.
Repeatable, reliable results.
To contact Hologic Australia and New Zealand about Viral Load Monitoring | Aptima HCV Quant Dx Assay use Get a quote.
Demand More from Your HCV NAAT
The Aptima HCV Quant Dx assay detects and quantitates HCV RNA and is intended for use as an aid in:
The Aptima HCV Quant Dx Assay intended use is to:
Confirm HCV Infection
Monitor Viral Load
HCV Treatment Is Evolving. Now HCV Testing Is Too.
The Aptima HCV Quant Dx assay meets the 2021 American Association for the Study of Liver Diseases (AASLD) recommendations for an FDA-approved quantitative or qualitative nucleic acid test (LoD ≤25 IU/mL) to determine sustained virological response (SVR). It employs real-time transcription-mediated amplification (RT-TMA) technology on Hologic’s Panther® system—and gives you unparalleled performance across several essential parameters.
Performance by design
The robust design of the Aptima HCV Quant Dx assay incorporates multiple primers and probes within a highly conserved region of HCV RNA (5’ UTR) to detect and quantitate across genotypes 1 – 6:
Redefining sensitivity: Detect even the lowest-level concentrations of HCV across all major genotypes and quantify HCV for optimal treatment monitoring.
Repeatable, reliable results.
To contact Hologic Australia and New Zealand about Viral Load Monitoring | Aptima HCV Quant Dx Assay use Get a quote.
Thanks for your help!
Sorry! Unable to submit your request at this time. Please try again later.
Report this product